Objective: Congenital dislocation of the hip (CDH), which is one of the most common congenital skeletal disorders, corresponds to an abnormal seating of the femoral head in the acetabulum. It is commonly admitted that CDH presents a genetic component. However, little is known about the genetic factors involved. This study aimed to determine the role of two potential candidate genes on chromosome 17 in CDH: HOXB9 (involved in limb embryonic development) and COL1A1 (involved in joint laxity).
Introduction
Congenital dislocation of the hip (CDH e OMIM #142700) is one of the most common congenital skeletal disorders. It results from an abnormality of the seating of the femoral head in the acetabulum 1e3 . The condition, which affects mainly females (sex-ratio: 1:8), may induce severe functional handicap if not treated early, and increases risk to develop hip osteoarthritis 4, 5 . CDH is particularly frequent in Caucasian populations, with an incidence about 1e10 per 1000 live births. Clusters of CDH have been observed in some ethnic groups such as the Navajo Indians (67/1000) 6 and the Lapps (50/1000) 7 , but this condition is also very common in our area (Finistè re, western Brittany, France). An epidemiological study performed in the 1960s showed that the incidence among girls reached 38/1000 in a specific area called ''Pays Bigouden'' 8, 9 . Besides a mechanical component linked to the pregnancy and delivery conditions, it is commonly admitted that CDH presents a genetic component. The main factors that argue in favor of a genetic determination for the disease are the ethnic predisposition and the familial aggregation observed. Higher recurrence risks of CDH have been reported in first-degree relatives of patients 10, 11 , as well as higher concordance in monozygotic than in dizygotic twins (40% vs 3%) 12 . The hereditary transmission has also been highlighted in a large segregation analysis performed on 171 pedigrees 13 . In addition, the availability of animal models supports the genetic hypothesis. Hip dysplasia occurs with a high frequency in some breed canine varieties, such as German Shepherd dogs and Labrador *Address correspondence and reprint requests to: Virginie Scotet, Inserm U613 « Gé né tique molé culaire et gé né tique é pidé miologique », 46 15e17 . CDH can be considered as a multifactorial disease, however little is known about the genetic factors involved. It has been suggested that the genetic predisposition to CDH could involve two genetic systems: the first one linked to acetabular dysplasia (corresponding to a shallow acetabulum at birth) and the second one linked to capsular joint laxity (corresponding to a weak mechanical resistance of the capsule that could result from a defect of the connective tissue) 18e20 . The genetic factors involved in CDH may therefore affect acetabular morphology or capsular laxity. Two genes located on chromosome 17 at position 17q21.3 appear as interesting candidate genes. The first one e HOXB9 e is included in a cluster of Homeobox genes and the encoded protein functions as a sequence-specific transcription factor, which is involved in cell proliferation and differentiation. The HOX genes are essential for limb development, where they participate in both growth and organization of the structures 21, 22 . The second gene e COL1A1 e belongs to the superfamily of genes encoding collagen; it encodes the a1 chain of collagen type 1. Such genes are of particular interest because of their involvement in resistance and elasticity of the tissues. They have been associated with a large spectrum of diseases such as EhlerseDanlos syndrome, osteogenesis imperfecta, chondrodysplasia and low bone mineral density 23 . Moreover, biochemical studies have shown that CDH is associated with alterations in the metabolism of collagen, which could explain the joint laxity observed 24 . The involvement of these two genes in CDH has been suggested by a Chinese study which, later on, refuted the implication of COL1A1 25, 26 . In view of these ambiguous findings, we proposed to study the association between HOXB9 and COL1A1 genes and CDH in our area (western Brittany, France) where this condition is particularly frequent. We used both case-control and family-based approaches to examine the role of these genes.
Method

STUDY DESIGN
In order to determine whether HOXB9 and COL1A1 may play a role in CDH, we set up a genetic-based association study in the area of Finistè re (Brittany, western France) where that condition is particularly frequent 8, 9 . Four centres involved in the screening and treatment of CDH in this area participated in the study (Hospital of Brest, Pont L'Abbé , Quimper and Roscoff) (Fig. 1) .
POPULATION UNDER STUDY
We carried out a case-control association study which included 239 unrelated patients and 239 healthy subjects mostly from western Brittany. Patients were mainly recruited in the four study centres by expert surgeons, who also validated the inclusion of the patients followed in other medical centres. The recruiting was done both prospectively (for the younger patients) and retrospectively (for the older ones). The diagnosis of CDH was made on the basis of clinical criteria and ultrasound and/or radiographic examination depending on the age and time of treatment. Only severe cases were enrolled in the study, what corresponded to the grades III and IV of the sonographic classification proposed by Graf and Wilson for newborns 27 . For adults, the classification relies on the VCE (vertical center edge or Wiberg angle e <20
) and HTE (horizontal toit externe or Tö nnis angle e >12 ) angle measures, which respectively assess the coverage and the inclination of the acetabulum. Patients with elastic tissue diseases (EhlerseDanlos, Larsen and Marfan syndromes, osteogenesis imperfecta) or karyotype abnormalities were excluded from the study. All the selection criteria had been uniformly applied by the different study centres.
Healthy subjects were blood donors from the same area or patients consulting in one of the four study centres. They did not have any family history of CDH or hip disorders. The control group was matched for gender, age and ethnic origin. Although the population of western Brittany is relatively ethnically homogeneous (mostly of Celtic origin), we constructed a match for ethnic origin in order to minimize the risk of population substructure.
We completed the study of the two genes by using a family-based approach which relied on the transmission disequilibrium test (TDT). Analyses were carried out from a sample of 81 complete trios composed of patients from the case-control study and their both parents (i.e., patients for whom we were able to obtain a blood sample for both parents).
Participation in the research protocol included the answer to a questionnaire (which provides information notably on family history and on mechanical factors) and the collection of a blood sample by venipuncture. The blood samples were prepared in accordance with usual procedures. DNA was extracted by a salting-out method and stored at À20
C. This research protocol was approved by our local Ethics Committee. Written informed consent was obtained for all subjects prior to their inclusion in the study.
SELECTION AND GENOTYPING OF MARKERS
The two candidate genes we analyzed are located on chromosome 17 and separated by 1.4 million base pairs (bp). The first one, HOXB9, is located at position 17q21.3. It contains two exons and covers a region of 5317 bp. The second one, COL1A1, is located at position 17q21.33. It is a long gene which contains 51 exons and covers a region of 17,543 bp.
The role of these two candidate genes in CDH was studied by choosing several single nucleotide polymorphisms (SNPs) in each gene. The set of informative SNPs (called tagSNPs) was selected using the Tagger software (http://www.broad.mit.edu/mpg/tagger/) 28 , which integrates the data of the HapMap Project 29e32 . This selection was made in reference to the Caucasian population (CEU population), ensuring that all the SNPs with a minor allele frequency !5% have a pair-wise r 2 ! 80% with at least one of the tagSNPs. Respectively two and eight SNPs were selected in the HOXB9 and COL1A1 genes (HOXB9: rs8844 and rs2303486; COL1A1: rs1061947, rs2586488, rs2075559, rs2857396, rs2696247, rs2141279, rs17639446 and rs2075555). Two additional SNPs were selected in the 3 0 and the 5 0 regions of the longest gene (COL1A1: rs909102 and rs1107946). Genotyping of SNPs was performed by an allelic discrimination technique (SNaPshot Ò ) on an ABI Prism 3130 instrument (Applied Biosystems, Inc.). We also genotyped, in our sample of trios, the microsatellite marker studied by the Chinese team (D17S1820) 25 . Success rate of genotyping was 100%. In order to validate the accuracy of genotyping results, we decided to retest, with an alternative technique (direct sequencing), 10% of the samples (for the SNPs showing the more divergent allelic frequencies from those observed in HapMap).
STATISTICAL ANALYSIS
First, deviation of genotype frequencies from HardyeWeinberg equilibrium (HWE) was tested for each SNP using the Finetti software (http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). As illustrated in Table I , all markers were in HWE and could therefore be considered for further analyses. Then, we checked if the allelic frequencies observed in our study were correlated with those observed in the HapMap database for the CEU population. We obtained an overall correlation coefficient of 80.1% (Table  I) . PGA software was also used to perform power calculations 33 .
Case-control association study
First, we tested the association between each marker and CDH using the SAS software (version 9.1 e SAS Institute, Cary, NC, USA). Logistic Fig. 1 . Centres involved in the study. regression models were used to estimate the strength of the associations through calculation of odds-ratio (OR) with their 95% confidence interval (95% CI). The alternative patterns of inheritance (dominant, recessive and multiplicative) were tested for each SNP by using a specific coding of the ''genotype'' variable. To account for multiple testing, the Bonferroni correction was applied. This consists in dividing the usual significance level of 5% (i.e., the type I error rate called a) by the number of tests (i.e., markers Â genetic models) carried out in order to assure an overall significance level of not more than 5%. The analyses were conducted by considering all patients, and then by excluding patients with the main risk factors known in CDH beyond gender (breech presentation and family history of CDH).
After this single-locus association analysis, we carried out a haplotypebased association study using Haploview (v4.0, http://www.broad.mit.edu/ mpg/haploview/) 34 and Thesias (http://genecanvas.ecgene.net/uploads/Thesias_Java_interface/) 35 . Haploview was used to visualize the structure of pair-wise linkage disequilibrium (LD) between the markers (in terms of Lewontin's D 0 and r 2 ), and to define haplotype blocks within each gene. Haplotype frequencies were estimated from genotyping data using the stochastic EM algorithm, and compared using the c 2 test. In addition, Thesias enabled us to test the association between the haplotypes and CDH by performing a test of likelihood ratio (LRT) and by calculating OR with their 95% CIs.
TDT
We completed the analysis of the two candidate genes by performing the TDT with the SNPs selected for the case-control study. As mentioned above, we also performed this test with the microsatellite marker D17S1820 located between the two genes. The TDT, which is insensitive to population subtructure 36 , is based on trios composed of affected individuals and both parents. It determines whether a marker allele (or an haplotype) is preferentially transmitted by heterozygous parents to their affected offspring 37 . The TDT was carried out using the Etdt software 38 whereas the haplotype-TDT analysis was performed using Haploview 34 .
Results
DESCRIPTION OF THE SAMPLE OF CDH PATIENTS
The present study included 239 CDH patients, 91.2% of whom were women (n ¼ 218), leading to a sex-ratio of 1:10. A radiographic image of a case is shown in Fig. 2 . Overall, the condition was more often bilateral (60.8% vs 39.2%, P ¼ 0.016), but when it was unilateral, it affected as often the left as the right hip (50.5% vs 49.5%, P ¼ 0.854). Close to 80% of the patients had a positive family history of CDH (n ¼ 188).
As our questionnaire gives information on the main mechanical factors known to be involved in CDH, we described the frequency of these factors in our series. Breech presentation was observed in 12.5% of the CDH cases and high birthweight (!4 kg) in 15.1% of them. CDH affected the first sibling in 42.7% of cases and three patients were part of multiple pregnancies. The proportion of postmature babies (!42 weeks of gestation) was 5.9%. A postural anomaly was observed in 11.4% of the CDH patients. Among these mechanical factors, only breech presentation was significantly more frequent in cases than in controls (12.5% vs 1.4%, OR ¼ 10.1 [3.0e34.5], P < 0.0001). Joint hyperlaxity was present in 11.0% of them and was also significantly more frequent in cases than in controls (11.0% vs 1.8%, OR ¼ 6.7 [2.3e19.7], P < 0.0001).
RESULTS OF THE CASE-CONTROL STUDY
The case-control study was based on 239 patients and 239 controls. Two SNPs were genotyped in the HOXB9 gene, and 10 in the COL1A1 gene. Genotyping was successful for all the markers in the whole sample. The accuracy of genotyping was validated in the way that the sequencing results of the retested markers did not differ from those obtained initially.
Single-locus association study
No significant association was observed between the two polymorphisms selected in HOXB9 and CDH. In contrast, a weak association tended to be observed for two of the SNPs selected in COL1A1, this before applying the Bonferroni correction. The concerned markers were rs2857396 (CC vs CT þ TT: OR ¼ 0.26 [0.07e0.96], P ¼ 0.043) and rs1107946 (AA þ AC vs CC: OR ¼ 0.63 [0.41e0.98], P ¼ 0.038), for which study power was respectively assessed to 90% and 67%. However, the significance of these results did not survive correction for multiple testing. Moreover, the complementary analyses performed in the subgroup of patients without breech presentation and in the subgroup without family history revealed no significant association (data available upon request).
Haplotype-based association study LD and haplotype blocks observed for the two genes revealed a single haplotype block in HOXB9 and three blocks in COL1A1 (Fig. 3) . Results of the haplotype analysis for each gene are presented in Tables IIa and b . For HOXB9, haplotype frequencies did not differ between cases and controls. In contrast, for COL1A1, a weak association tended to be observed for the third haplotype block (LRT ¼ 7.2, P ¼ 0.0280) which included the markers rs2075555 and rs1107946, the latter being associated with CDH in the single-locus analysis. More precisely, frequency of the CC haplotype was estimated at 89.7% in cases and 85.3% in controls (P ¼ 0.0396), whereas frequency of the CA haplotype was estimated at 0.6% in cases and 2.5% in controls (P ¼ 0.0193). Thus, by considering the most common haplotype (CC) as reference, the OR associated with the CA haplotype was 0.23 (95% CI ¼ [0.06e0.84], P ¼ 0.026). Again, the significance of all these findings disappeared after correction for multiple testing.
RESULTS OF THE TDT
Analysis of the family data set revealed similar negative findings. Table III shows, for each of the SNPs selected in the HOXB9 and COL1A1 genes, the ratio of transmissions to nontransmissions of the possibly overtransmitted allele from heterozygous parents to their affected offspring. This analysis did not reveal preferential transmission of any alleles of the selected markers. The haplotype-based analysis found similar results. In the same way, no transmission disequilibrium was observed for any of the 16 alleles of the microsatellite marker D17S1820.
Discussion
The present study examines the involvement of two genes on chromosome 17 (HOXB9 and COL1A1) in CDH in a Caucasian population where the incidence of that condition is high. These genes may play a role in acetabular dysplasia or joint laxity, and are therefore interesting candidate genes.
Our findings do not support the role of these two genes in CDH in our population. They are consistent with the results observed in a Chinese population for the COL1A1 gene 26 . Our negative findings were obtained by two different approaches (case-control and family-based studies) that rely both on single-locus and haplotype-based analyses. Moreover, our study used selection methods of informative markers based on LD information, contrary to previous studies which usually consisted in genotyping only one or two genetic markers per gene. Our sample is also one of the largest used to date in genetic studies carried out on CDH (even if it remains of modest size for such kind of studies). It should nevertheless be noted that family history of CDH appears particularly frequent in our study. This could be the result of several phenomena (high incidence of CDH in our region, lack of accuracy of the variable based on patients' responses) and may have induced a selection bias. Nevertheless, the results remain unchanged in the subgroup of patients without family history. It is commonly admitted that CDH involves genetic and mechanical factors. The mechanical component is linked to the conditions of pregnancy and delivery. It mainly corresponds to factors that reduce the mobility of the fetus in the womb and induce excessive pressure on the flexed thighbone. Among them, we note breech presentation, oligoamnios, primiparity, high birthweight, postmaturity and presence of postural anomalies 39 . Besides this mechanical component, the observation of clusters of CDH and the familial nature of the condition suggest the existence of a genetic component for CDH. Familial studies have reported higher risks of recurrence for first-degree relatives and showed that those risks increased if several children or two generations were affected 10 . Moreover, twin studies have shown a higher concordance of CDH in monozygotic twins (40%) compared with dizygotic ones (3%) 12 . Several authors suggested, in the 1960s, that two genetic models could be responsible for the etiology of CDH: one linked to acetabular dysplasia and one linked to joint laxity 18, 19 . Such laxity might result from an anomaly of the connective tissue. Czeizel et al. showed that CDH patients had a more extensible metacarpophalangeal joint of the index than nondislocated subjects, and that this persistent laxity was often found among first-degree relatives (in 25% of parents of cases, in 36% of siblings of cases) 20 . The two models proposed seem to differ both in their genetic mechanism and in the age at which they anticipate diagnosis. It was proposed that the genetic mechanism responsible for anatomic configuration of the hip should be of polygenic nature whereas that responsible for joint laxity should be of monogenic nature 19, 20 . Moreover, cases linked to acetabular dysplasia are usually diagnosed later than cases linked to joint laxity, which may be detected at birth by the OrtolanieBarlow maneuvres 40 . Few studies have tried to dissect the genetic basis of CDH with the genetic tools currently available. To date, only four genetic-based association studies and one linkage analysis have been carried out 25,26,41e43 and most of them have obtained negative results.
The first association study performed on CDH was conducted in 2003 by a Chinese team and was published in a Chinese journal 25 . It was a family-based study which examined the role of HOXB9 and COL1A1 in CDH using the TDT approach. The authors genotyped a single microsatellite marker (D17S1820) located between these two genes in 101 trios. They observed a transmission disequilibrium for one of the twelve alleles identified in their sample (P ¼ 0.014), leading them to suggest that these genes could confer susceptibility to CDH. Nevertheless, it should be noted that these genes are distant from each other; the region separating them covers 1.4 million bp and contains more than 20 other genes. We performed the same test in our sample of trios, and did not observe any transmission disequilibrium for any of the alleles of this marker. However, our sample size (81 trios) remains small.
Thereafter, this team examined the role of COL1A1 more thoroughly by selecting two polymorphisms within this large gene 26 . The authors did not observe preferential transmission in that instance, and concluded that COL1A1 was not a major susceptibility gene. However, they reported that the allelic frequency of these markers in the Chinese population differed significantly from that observed in two Caucasian populations, thus retaining the possibility of an association between COL1A1 and CDH within populations of other ethnic origins. A recent study reported that mRNA and protein expression of COL1A1 was significantly decreased in the capsule of children with development dislocation of the hip 44 . Despite these experimental findings, our study indicates that COL1A1 does not play a major role in the etiology of CDH in our Caucasian population.
In 2007, an English team tested the association between two genes involved in metabolism and development of bone and developmental hip dysplasia (DDH): ESR1 encoding the estrogen receptor (located on chromosome 6) and VDR encoding the vitamin D receptor (located on chromosome 12) 41 . The authors, who carried out a case-control study (45 patients and 101 controls), selected two polymorphisms within each gene and observed no significant association.
Another case-control association study was conduced by an Italian team in 2002, but not directly on CDH. This study, based on 143 patients and 50 controls, analyzed the role of two adjacent genes on the chromosome 12 (COL2A1 and VDR) in osteoarthritis secondary to hip dysplasia 45 . One genetic marker was genotyped in each gene, and a significant association was found with the marker selected in COL2A1 (P ¼ 0.03). However, the role of these two genes in DDH was recently excluded by a linkage study done from a panel of 11 families (study based on the analysis of three microsatellite markers covering the region containing these two genes) 42 . An other linkage study, based on a genomewide screening, was done in a Japanese family with osteoarthritis of the hip joint associated with acetabular dysplasia, and revealed a region of interest on the chromosome 13 (13q22) 46 . The first report of a positive association between one gene and CDH was done very recently by a Chinese 43 . This case-control study, based on 338 patients and 622 controls, found a significant association between a functional SNP (rs143383) located in the 5 0 UTR of the GDF5 (growth differentiate factor 5) gene which plays a crucial role in joint morphogenesis. This SNP was already found to be associated with osteoarthritis susceptibility in both Asian and European populations 47e49 . In conclusion, to date, only one gene involved in the etiology of CDH has been reported (GDF5). The other studies have excluded the role of several genes in CDH (COL1A1 in a Chinese population) or in DDH (COL2A1, ESR1 and VDR in Caucasian populations). Our study do not support the involvement of HOXB9 and COL1A1 in a Caucasian population.
Analysis of the genetic component of CDH needs further investigations and should focus on other candidate genes. Identification of the genetic factors involved in CDH should advance understanding of the respective roles of genetic and environmental factors in that complex disease. It would furthermore avoid late diagnosis and treatment, and promote earlier identification of patients at risk of developing hip osteoarthritis.
